Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps NHS England has taken to help identify (a) children and (b) adults at risk of pre‑symptomatic Type 1 diabetes; and what assessment has been made of (i) the uptake and (ii) effectiveness of those services.

The National Institute for Healthcare Research is funding the EarLy Surveillance for Autoimmune diabetes (ELSA) study into the feasibility of screening for type 1 diabetes in children aged three to 13 years old. The ELSA study has tested over 24,000 people and is being run through schools, general practice surgeries, as well as through online recruitment.

The UK National Screening Committee advises the National Health Service on screening programmes and, in 2019, concluded that more research and evidence for the benefits of screening for autoimmune type 1 diabetes was required.